ArticleOncotarget2015

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.

Tobias Kessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.